Lululemon Athletica Inc. (NASDAQ:LULU), a leading designer and retailer of athletic apparel with a market capitalization of $47.3 billion, has experienced a mix of successes and challenges in recent ...
Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...